Vinorelbine oral

DRUG4 trials

Sponsors

Hellenic Oncology Research Group, Pierre Fabre Pharma GmbH, Guangdong Association of Clinical Trials, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

Breast CancerLung Neoplasm MalignantMetastatic Breast CancerNSCLC (Advanced Non-small Cell Lung Cancer)Non-Small-Cell Lung Cancer

Phase 1

Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer

CompletedNCT00706069

Hellenic Oncology Research GroupMetastatic Breast Cancer

Start: 2008-06-30End: 2009-07-31Target: 40Updated: 2009-12-15

Phase 2

Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer

TerminatedNCT02985203

Guangdong Association of Clinical TrialsLung Neoplasm Malignant

Start: 2016-11-30End: 2018-04-30Updated: 2020-03-12

Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

RecruitingNCT07001618

Gustave Roussy, Cancer Campus, Grand ParisNSCLC (Advanced Non-small Cell Lung Cancer)

Start: 2025-11-17End: 2032-09-01Target: 162Updated: 2026-04-03

Unknown Phase

Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria

CompletedNCT02619929

Pierre Fabre Pharma GmbHBreast Cancer, Non-Small-Cell Lung Cancer

Start: 2016-02-29End: 2018-03-31Updated: 2018-08-29